Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
---|---|---|---|---|---|
FIREFLY NEUROSCIENCE Aktie jetzt für 0€ handeln | |||||
Mi | Firefly Neuroscience, Inc.: Firefly Neuroscience to Participate in the 8th Annual Florida Capital Event | 1 | GlobeNewswire (USA) | ||
01.11. | FIREFLY NEUROSCIENCE, INC. - 8-K, Current Report | 1 | SEC Filings | ||
25.10. | Firefly Neuroscience, Inc.: Firefly Neuroscience Announces Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) | 105 | GlobeNewswire (Europe) | TORONTO, Oct. 25, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve... ► Artikel lesen | |
21.10. | Bright Minds Biosciences and Firefly Neuroscience to Collaborate After the BREAKTHROUGH Study: A Phase 2 Trial of BMB-101 in Absence Epilepsy and Developmental Epileptic Encephalopathy for Full Analysis of EEG Data | 9 | GlobeNewswire (USA) | ||
16.10. | Firefly Neuroscience, Inc.: Firefly Neuroscience Collaborates with Bright Minds Biosciences to Analyze the Data from its Positive Phase 1 Study using its Artificial Intelligence, FDA-Cleared BNA Technology | 148 | GlobeNewswire (Europe) | TORONTO, Oct. 16, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve... ► Artikel lesen | |
15.10. | Firefly Neuroscience, Inc.: Firefly Neuroscience Announces Use of Its Brain Network Analytics Platform in Phase 1 Study of SP-624, the First Potential Treatment Designed for Women with Major Depressive Disorder | 55 | GlobeNewswire (Europe) | TORONTO, Oct. 15, 2024 (GLOBE NEWSWIRE) -- Firefly Neuroscience, Inc. ("Firefly," or the "Company") (NASDAQ: AIFF), an Artificial Intelligence ("AI") company developing innovative solutions that improve... ► Artikel lesen | |
04.10. | AIFF-Aktie erreicht 52-Wochen-Tief bei 2,74 US-Dollar | 1 | Investing.com Deutsch | ||
04.10. | AIFF stock touches 52-week low at $2.74 amid market challenges | 1 | Investing.com | ||
27.09. | Firefly Neuroscience files to sell 2.56M shares for holders | 1 | Seeking Alpha | ||
27.09. | FIREFLY NEUROSCIENCE, INC. - S-1, General form for registration of securities | 1 | SEC Filings | ||
26.09. | AIFF Stock Hits 52-Week Low at $2.99 Amid Market Challenges | 1 | Investing.com | ||
20.09. | Firefly Neuroscience, Inc.: Firefly Neuroscience Advances AI-Driven BNA Technology in Neuroscience Drug Development after Completing Successful Research Collaborations with Takeda and Novartis | 16 | GlobeNewswire (USA) | ||
11.09. | Zeto inks partnership with Firefly Neuroscience | 1 | MassDevice | ||
10.09. | Firefly Neuroscience, Inc.: Firefly Neuroscience Announces Partnership with Zeto to Integrate and Distribute its BNA Technology with Zeto's FDA-Cleared EEG Device Platform | 1 | GlobeNewswire (USA) | ||
09.09. | AIFF stock touches 52-week low at $3.12 amid market challenges | 1 | Investing.com | ||
05.09. | Firefly Neuroscience, Inc.: Firefly Neuroscience Appoints Dr. Stella Vnook to its Board of Directors | 1 | GlobeNewswire (USA) | ||
26.08. | Firefly Neuroscience, Inc.: Firefly Neuroscience CEO Jon Olsen to Present at H.C. Wainwright's 26th Annual Global Investment Conference September 9-11 | 1 | GlobeNewswire (USA) | ||
22.08. | Firefly Neuroscience, Inc.: Firefly Neuroscience, an AI-Driven Brain Health Company, to Host Shareholder Update Call on September 4th | 1 | GlobeNewswire (USA) | ||
21.08. | Firefly Neuroscience, Inc.: Firefly Neuroscience Forms Strategic Partnership with Neurology Consultants of Dallas (NCD) to Enhance Early Detection Efforts and Disease Management for Patients with Cognitive Disorders | 1 | GlobeNewswire (USA) | ||
20.08. | Firefly Neuroscience expands board, appoints new directors | 1 | Investing.com |
Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
---|---|---|---|---|---|
SIEMENS HEALTHINEERS | 52,00 | -0,38 % | UBS stuft Siemens Healthineers auf 'Neutral' | ZÜRICH (dpa-AFX Analyser) - Die Schweizer Großbank UBS hat die Einstufung für Siemens Healthineers mit einem Kursziel von 51 Euro auf "Neutral" belassen. Das vierte Geschäftsquartal sei solide verlaufen... ► Artikel lesen | |
THERMO FISHER | 512,00 | -0,27 % | Research and Markets: European Life Science Tools and Reagents Market Research 2023-2024 & 2029: Thermo Fisher Scientific, Danaher., Merck, Qiagen and Roche Lead the Industry - ResearchAndMarkets.com | The "European Life Science Tools and Reagents Market" report has been added to ResearchAndMarkets.com's offering.
The European market for life science tools and reagents and COVID-19 diagnostics... ► Artikel lesen | |
HIMS & HERS HEALTH | 26,690 | +1,99 % | Opening Bell: Trump Media, Palantir, Ferrari, Boeing, Cummins, Hims & Hers Health | Wer wird der nächste US-Präsident? Diese Frage beschäftigt gerade die Märkte. Heute wird gewählt, deshalb hielten sich die Anleger an der Wall Street gestern erneut zurück. Dow Jones und Co. verzeichneten... ► Artikel lesen | |
CARDINAL HEALTH | 115,40 | +1,05 % | Cardinal Health Stock Sees IBD RS Rating Improve To 71 | ||
RESMED | 233,70 | +0,04 % | Dividendenbekanntmachungen (07.11.2024) | Unternehmen ISIN-Code Dividende (Währung) Dividende (EUR) AIRTEL AFRICA PLC GB00BKDRYJ47 0,02 GBP 0,024 EUR AKZO NOBEL NV ADR US0101995035 0,1583 USD 0,1475 EUR ALLIANCE RESOURCE PARTNERS... ► Artikel lesen | |
HEALWELL AI | 1,270 | +7,17 % | EQS-Media: HEALWELL AI Inc.: Die Expansion geht weiter: HEALWELL forciert Vermarktungsmaßnahmen und erweitert Partnerschaften im Pharmabereich | EQS-Media / 06.11.2024 / 07:30 CET/CEST
HEALWELL AI Inc. (ISIN: CA42249X1006; WKN: A3EWDE), ein Technologieunternehmen im Gesundheitswesen, das auf den Einsatz von KI und Datenwissenschaft... ► Artikel lesen | |
ORGANON | 15,150 | +0,36 % | Looking Into Organon's Recent Short Interest | ||
VIVANI MEDICAL | 1,180 | -0,84 % | Vivani Medical Provides Business Update and Reports Second Quarter 2024 Financial Results | ALAMEDA, Calif.--(BUSINESS WIRE)--Vivani Medical, Inc. (Nasdaq: VANI) ("Vivani" or the "Company"), a biopharmaceutical company developing miniaturized, long-acting drug implants, today reported... ► Artikel lesen | |
MEDICAL FACILITIES | 9,500 | 0,00 % | Medical Facilities Corporation Announces 2024 Third Quarter Results | ||
MEDCAP | 49,350 | 0,00 % | MEDCAP AB: Profit growth, stronger cash flow and acquisitions | ||
GENEDX | 73,44 | 0,00 % | GeneDx Reports Third Quarter 2024 Financial Results and Business Highlights | STAMFORD, Conn.--(BUSINESS WIRE)--GeneDx Holdings Corp. (Nasdaq: WGS), a leader in delivering improved health outcomes through genomic insights, today reported its financial results for the third... ► Artikel lesen | |
BRAINSWAY | 10,840 | 0,00 % | BrainsWay Q3 Earnings Preview | ||
FRESENIUS | 33,500 | -1,03 % | DAX-Check LIVE: BWM, CoBa, Elmos, Evotec, Fresenius, Henkel, Puma, Siemens Healthineers & Co. | Am Tag der US-Wahl kam der DAX zunächst nicht vom Fleck. Im Windschatten einer freundlichen Wall Street verbuchte er am Nachmittag dann aber doch Zugewinne. Er ging schließlich mit einem Plus von 0... ► Artikel lesen | |
FRESENIUS MEDICAL CARE | 40,260 | +1,41 % | DAX-Check LIVE: CoBa, Evotec, Fraport, FMC, Hugo Boss, Krones, Redcare, Salzgitter, Schaeffler & Co. | Um 0,56 Prozent ging es gestern abwärts für den deutschen Leitindex. Am Vormittag noch pendelte er um seinen Schlusskurs vom vergangenen Freitag. Die Mehrheit der Anleger wollte sich vor den heute stattfindenden... ► Artikel lesen | |
TEMPUS AI | 77,56 | 0,00 % | Tempus AI downgraded to hold by Stifel, valuation cited |